MedTrace Logo

A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting

NCT03160040 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2023-08-28

No results posted yet for this study

Summary

This study is a retrospective, observational study to evaluate minocycline use in participants under real world conditions.

Conditions

  • Gram-Negative Bacterial Infections

Interventions

DRUG

Minocycline IV

This study is an observational study. All participants were administered minocycline IV prior to enrollment in this study.

Sponsors & Collaborators

  • Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)

    lead INDUSTRY

Principal Investigators

  • Medical Information · Melinta Therapeutics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-11
Primary Completion
2018-05-01
Completion
2018-05-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03160040 on ClinicalTrials.gov